Cargando…

HHV-8 seroprevalence: a global view

BACKGROUND: Human herpes virus 8 (HHV-8) is the underlying infectious cause of Kaposi sarcoma (KS) and other proliferative diseases; that is, primary effusion lymphoma and multicentric Castleman disease. In regions with high HHV-8 seroprevalence in the general population, KS accounts for a major bur...

Descripción completa

Detalles Bibliográficos
Autores principales: Rohner, Eliane, Wyss, Natascha, Trelle, Sven, Mbulaiteye, Sam M, Egger, Matthias, Novak, Urban, Zwahlen, Marcel, Bohlius, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925012/
https://www.ncbi.nlm.nih.gov/pubmed/24521144
http://dx.doi.org/10.1186/2046-4053-3-11
_version_ 1782303801107021824
author Rohner, Eliane
Wyss, Natascha
Trelle, Sven
Mbulaiteye, Sam M
Egger, Matthias
Novak, Urban
Zwahlen, Marcel
Bohlius, Julia
author_facet Rohner, Eliane
Wyss, Natascha
Trelle, Sven
Mbulaiteye, Sam M
Egger, Matthias
Novak, Urban
Zwahlen, Marcel
Bohlius, Julia
author_sort Rohner, Eliane
collection PubMed
description BACKGROUND: Human herpes virus 8 (HHV-8) is the underlying infectious cause of Kaposi sarcoma (KS) and other proliferative diseases; that is, primary effusion lymphoma and multicentric Castleman disease. In regions with high HHV-8 seroprevalence in the general population, KS accounts for a major burden of disease. Outside these endemic regions, HHV-8 prevalence is high in men who have sex with men (MSM) and in migrants from endemic regions. We aim to conduct a systematic literature review and meta-analysis in order 1) to define the global distribution of HHV-8 seroprevalence (primary objective) and 2) to identify risk factors for HHV-8 infection, with a focus on HIV status (secondary objective). METHODS/DESIGN: We will include observational studies reporting data on seroprevalence of HHV-8 in children and/or adults from any region in the world. Case reports and case series as well as any studies with fewer than 50 participants will be excluded. We will search MEDLINE, EMBASE, and relevant conference proceedings without language restriction. Two reviewers will independently screen the identified studies and extract data on study characteristics and quality, study population, risk factors, and reported outcomes, using a standardized form. For the primary objective we will pool the data using a fully bayesian approach for meta-analysis, with random effects at the study level. For the secondary objective (association of HIV and HHV-8) we aim to pool odds ratios for the association of HIV and HHV-8 using a fully bayesian approach for meta-analysis, with random effects at the study level. Sub-group analyses and meta-regression analyses will be used to explore sources of heterogeneity, including factors such as geographical region, calendar years of recruitment, age, gender, ethnicity, socioeconomic status, different risk groups for sexually and parenterally transmitted infections (MSM, sex workers, hemophiliacs, intravenous drug users), comorbidities such as organ transplantation and malaria, test(s) used to measure HHV-8 infection, study design, and study quality. DISCUSSION: Using the proposed systematic review and meta-analysis, we aim to better define the global seroprevalence of HHV-8 and its associated risk factors. This will improve the current understanding of HHV-8 epidemiology, and could suggest measures to prevent HHV-8 infection and to reduce its associated cancer burden.
format Online
Article
Text
id pubmed-3925012
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39250122014-02-15 HHV-8 seroprevalence: a global view Rohner, Eliane Wyss, Natascha Trelle, Sven Mbulaiteye, Sam M Egger, Matthias Novak, Urban Zwahlen, Marcel Bohlius, Julia Syst Rev Protocol BACKGROUND: Human herpes virus 8 (HHV-8) is the underlying infectious cause of Kaposi sarcoma (KS) and other proliferative diseases; that is, primary effusion lymphoma and multicentric Castleman disease. In regions with high HHV-8 seroprevalence in the general population, KS accounts for a major burden of disease. Outside these endemic regions, HHV-8 prevalence is high in men who have sex with men (MSM) and in migrants from endemic regions. We aim to conduct a systematic literature review and meta-analysis in order 1) to define the global distribution of HHV-8 seroprevalence (primary objective) and 2) to identify risk factors for HHV-8 infection, with a focus on HIV status (secondary objective). METHODS/DESIGN: We will include observational studies reporting data on seroprevalence of HHV-8 in children and/or adults from any region in the world. Case reports and case series as well as any studies with fewer than 50 participants will be excluded. We will search MEDLINE, EMBASE, and relevant conference proceedings without language restriction. Two reviewers will independently screen the identified studies and extract data on study characteristics and quality, study population, risk factors, and reported outcomes, using a standardized form. For the primary objective we will pool the data using a fully bayesian approach for meta-analysis, with random effects at the study level. For the secondary objective (association of HIV and HHV-8) we aim to pool odds ratios for the association of HIV and HHV-8 using a fully bayesian approach for meta-analysis, with random effects at the study level. Sub-group analyses and meta-regression analyses will be used to explore sources of heterogeneity, including factors such as geographical region, calendar years of recruitment, age, gender, ethnicity, socioeconomic status, different risk groups for sexually and parenterally transmitted infections (MSM, sex workers, hemophiliacs, intravenous drug users), comorbidities such as organ transplantation and malaria, test(s) used to measure HHV-8 infection, study design, and study quality. DISCUSSION: Using the proposed systematic review and meta-analysis, we aim to better define the global seroprevalence of HHV-8 and its associated risk factors. This will improve the current understanding of HHV-8 epidemiology, and could suggest measures to prevent HHV-8 infection and to reduce its associated cancer burden. BioMed Central 2014-02-12 /pmc/articles/PMC3925012/ /pubmed/24521144 http://dx.doi.org/10.1186/2046-4053-3-11 Text en Copyright © 2014 Rohner et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Protocol
Rohner, Eliane
Wyss, Natascha
Trelle, Sven
Mbulaiteye, Sam M
Egger, Matthias
Novak, Urban
Zwahlen, Marcel
Bohlius, Julia
HHV-8 seroprevalence: a global view
title HHV-8 seroprevalence: a global view
title_full HHV-8 seroprevalence: a global view
title_fullStr HHV-8 seroprevalence: a global view
title_full_unstemmed HHV-8 seroprevalence: a global view
title_short HHV-8 seroprevalence: a global view
title_sort hhv-8 seroprevalence: a global view
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925012/
https://www.ncbi.nlm.nih.gov/pubmed/24521144
http://dx.doi.org/10.1186/2046-4053-3-11
work_keys_str_mv AT rohnereliane hhv8seroprevalenceaglobalview
AT wyssnatascha hhv8seroprevalenceaglobalview
AT trellesven hhv8seroprevalenceaglobalview
AT mbulaiteyesamm hhv8seroprevalenceaglobalview
AT eggermatthias hhv8seroprevalenceaglobalview
AT novakurban hhv8seroprevalenceaglobalview
AT zwahlenmarcel hhv8seroprevalenceaglobalview
AT bohliusjulia hhv8seroprevalenceaglobalview